Dementia risk may be raised by hormone therapy for prostate cancer
A study published in JAMA Oncology found that men with prostate cancer who had ADT (androgen deprivation therapy) were nearly twice as likely to be diagnosed with dementia in the five years after the ADT treatment, compared to men who didn’t receive it.
http://www.medicalnewstoday.com/articles/313452.php
Related Posts
-
Pets may be linked to slower cognitive decline
Posted on Mar 24, 2022
-
Poor score on simple memory test may be linked to Alzheimer’s biomarkers
Posted on Mar 15, 2022
-
Hypertension in young adults affects brain later
Posted on Mar 8, 2022
-
Being lonely more often may raise dementia risk
Posted on Mar 3, 2022
Tags
Share This
